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The design and feasibility of whole-genome–association studies are critically dependent on the extent of linkage
disequilibrium (LD) between markers. Although there has been extensive theoretical discussion of this, few empirical
data exist. The authors have determined the extent of LD among 38 biallelic markers with minor allele frequencies
1.1, since these are most comparable to the common disease-susceptibility polymorphisms that association studies
aim to detect. The markers come from three chromosomal regions—1,335 kb on chromosome 13q12-13, 380 kb
on chromosome 19q13.2, and 120 kb on chromosome 22q13.3—which have been extensively mapped. These
markers were examined in ∼1,600 individuals from four populations, all of European origin but with different
demographic histories; Afrikaners, Ashkenazim, Finns, and East Anglian British. There are few differences, either
in allele frequencies or in LD, among the populations studied. A similar inverse relationship was found between
LD and distance in each genomic region and in each population. Mean D′ is .68 for marker pairs !5 kb apart and
is .24 for pairs separated by 10–20 kb, and the level of LD is not different from that seen in unlinked marker pairs
separated by 1500 kb. However, only 50% of marker pairs at distances !5 kb display sufficient LD ( ) to beD 1 .3
useful in association studies. Results of the present study, if representative of the whole genome, suggest that a
whole-genome scan searching for common disease-susceptibility alleles would require markers spaced 5 kb apart.
Introduction
Whole-genome–association studies using anonymous
single-nucleotide–polymorphism (SNP) markers are pro-
posed as a means to search for complex disease-suscep-
tibility genes. However, the feasibility of such studies is
presently under debate and is crucially dependent on the
extent of linkage disequilibrium (LD) across the genome.
There are known to be abundant SNPs spaced through-
out the genome that could be used as markers (Human
Genic Bi-Allelic SEquences, Human SNP Database at the
Received August 21, 2000; accepted for publication October 18,
2000; electronically published November 14, 2000.
Address for correspondence and reprints: Dr. Alison M. Dunning,
CRC Department of Oncology, University of Cambridge, Strangeways
Research Laboratory, Wort’s Causeway, Cambridge CB1 8RN, United
Kingdom. E-mail: alisond@srl.cam.ac.uk
∗ The first two authors contributed equally to this work.
† Present affiliation: Dipartimento di Biologia e Patologia Cellulare
e Moleculare, Facolta’ di Medicina e Chirurgia, Universita’ degli Studi
di Napoli “Frederico II”, Naples, Italy.
 2000 by The American Society of Human Genetics. All rights reserved.
0002-9297/2000/6706-0019$02.00
Whitehead Institute for Biomedical Research/MIT Cen-
ter for Genome Research, The SNP Consortium Ltd, and
CGAP Genetic Annotation Initiative). The SNP Con-
sortium had the original goal of generating a map of
300,000 SNPs (averaging 1 every 10 kb), but it now
expects at least to double this (Roberts 2000). Indepen-
dently, the U.S. National Human Genome Research In-
stitute proposed a 5-year plan to generate a high-reso-
lution SNP map of 100,000 anonymous SNPs. The
question remains as to how the markers for such a study
should be spaced to maximize coverage while minimiz-
ing the amount of genotyping—and hence the cost. Be-
cause empirical evidence—which is essential to inform
this debate—is very sparse, the present large study has
been designed specifically to generate such data.
Whole-genome–association studies require allelic as-
sociation (resulting from LD) to be detected between
the anonymous markers used and the disease-causing
allele, so that markers that are physically close to the
disease-causing allele will be recognized as being more
common among the subjects with disease than among
the control subjects. The main questions relating to the
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Figure 1 Relative positions of markers used in each chromosomal region. The blackened sections of the vertical bars correspond to the
markers, and the shaded boxes on chromosome 13 and 19 represent gene footprints. Details of each marker, in the order shown, are given in
table 1. A, Region 1 (chromosome 13q12-13). Of the eight markers within 1.3 Mb around the BRCA2 gene, the first and sixth markers are
microsatellites with bimodal allele distributions. B, Region 2 (chromosome 19q13.2). A 380-kb region with 12 SNP markers including the two
SNPs that create the ApoE protein polymorphism is depicted. C, Region 3 (chromosome 22q13.3-ter). Eighteen SNPs in 120 kb are depicted.
There are no known genes in this region. All markers were specifically selected to have rare-allele frequencies 1.1.
markers are (1) whether there is a strong relationship
between the distance between two markers and the de-
gree of LD between them and (2) whether this rela-
tionship is the same in all populations or whether re-
cently founded populations display LD across greater
distances. A third question—when one considers not
just LD but also the identification of disease alleles—is
the nature of these alleles. Are they, for example, recent
or ancient, unique or multiple? Although it is possible
that common diseases may be caused by multiple rare
disease alleles, it will be very difficult to identify rare
low-penetrance alleles by association studies. Therefore,
our main focus is on the search for common disease
alleles, which we assume will be ancient and similar in
behavior to the common SNPs used to detect them.
Kruglyak (1999) used population simulation to sug-
gest a marker design for a whole-genome approach. He
used several assumptions: (1) that the human popula-
tion remained small ( ) until expansion be-Np 10,000
ginning 5,000 generations ago, (2) that all SNPs had
arisen only once from a single mutation, and (3) that
all SNPs are neutral to selection. The simulations in-
dicated that all common SNPs must be ancient (110,000
generations old) and that marker pairs 13 kb apart
would not demonstrate useful LD. Additionally, unless
founder populations were derived from a very tight bot-
tleneck (so that any now-common variant would have
been introduced by only a few original founders), they
would not be more useful than would other populations
when the numbers of markers or subjects needed for an
entire scan are considered.
The few existing empirical studies suggest that these
predictions may not always be borne out in practice.
Peterson (1995) studied microsatellite markers in anon-
ymous regions of chromosome 4 in 50 people from the
Finnish founder population. Although tightly linked loci
more often showed strong LD, she also found LD be-
tween some markers that were 11 Mb apart. Laan and
Paabo (1997) also studied microsatellite loci, in a 12.5-
Mb region of chromosome Xq13 in males from the
Saami, Finnish, Estonian, and Swedish populations with
different demographic histories. They detected the most
extensive LD (even between markers 110 Mb apart) in
the Saami, an isolated founder population that has not
undergone recent expansion. Using common SNPs and
microsatellites, several researchers have found signifi-
cant LD between markers separated by distances of 100
kb to several megabase pairs (sometimes approximated
as cM) (Peterson et al. 1995; Collins and Morton 1998;
Huttley et al. 1999; Wright et al. 1999). Founder pop-
ulations have proved very useful for the assigning link-
age of some complex diseases, such as type 2 diabetes
in Mexican Americans (Hanis et al. 1996) and com-
bined hyperlipidemia in Finns (Pajukanta et al. 1998).
However, two very recently published papers have sug-
gested that the Finnish and Sardinian populations, at
least, do not display more LD than do other populations
when markers that are presumed to be ancient are con-
sidered (Eaves et al. 2000; Taillon-Miller et al. 2000).
Only a few long-distance physical maps of SNPs are
known. In the present study we have used three long,
high-resolution, genomic maps in which the marker or-
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der is known with certainty. These lie in different chro-
mosomal regions relative to the centromere and telo-
meres (fig. 1). We have examined the LD relationships
between these markers in four populations with differ-
ent demographic histories. The populations are the East
Anglian British (considered to be outbred) and three
founder populations: the Afrikaners, the Ashkenazim,
and the Finns of Kuopio. We have determined two mea-
sures of LD (disequilibrium coefficients D′ and D) be-
tween all marker pairs and have compared the values
obtained across physical distances and between popu-
lations, in an attempt to identify the important criteria
for designing whole-genome scans. We specifically se-
lected markers with rare-allele frequencies 1.1, since
these have greater polymorphism-information-content
values, which improve the power to detect LD (Ter-
williger et al. 1998), and they are most comparable to
the common disease-susceptibility polymorphisms that
association studies aim to detect.
Subjects and Methods
Population Samples and Their Demographic Histories
The East Anglian population consisted of 376 unre-
lated females taking part in the EPIC study of diet and
health (Day et al. 1999), a population-based study con-
ducted in the county of Norfolk in the East Anglian
region of southeastern England. Britain and Scandinavia
were the last regions of Europe to be populated by Ne-
olithic farmers ∼6,500 years (260 generations) ago (Cav-
alli-Sforza et al. 1994). Within East Anglia during the
past 2,000 years there has been admixture with Medi-
terranean peoples (Romans), Germanic peoples (Angles
and Saxons), Scandinavians (Vikings and French Nor-
mans), and people from The Netherlands. The original
Neolithic inhabitants may have been largely displaced
to more-westerly regions of the British Isles. The pop-
ulation size is estimated to have been 50,000 people at
the start of the last millennium, but the marshy geog-
raphy of the region has meant that the total population
has been dispersed as small, isolated communities until
the last four or five generations. The population of East
Anglia is now ∼500,000 people.
The Afrikaner population was drawn from 115 par-
ent-offspring triads, of whom only the 230 unrelated
parents were used in this study. Parents were considered
eligible if all four grandparents of their offspring were
of Afrikaner ancestry. The Afrikaners are mainly de-
scended from Dutch, German, and, to a lesser extent,
French immigrants to the South African Cape. By 1687
the founding population consisted of 90 families. How-
ever, there have also been more-recent emigrations
(Theal 1964). Although cultural isolation has been
strongly encouraged, the degree to which this has been
practiced is not known. There are now ∼2 million people
of Afrikaner ancestry in South Africa.
The Ashkenazi population consisted of 517 individ-
uals, who were unselected responders from a cohort of
1,200 recent immigrants to Israel from the former Soviet
Union (predominantly from the cities of Gomel and
Kiev). The Ashkenazim are a European Jewish popu-
lation who are thought to have migrated to Europe from
the Middle East almost 2,000 years ago, although it has
also been suggested that they are descended from a tribe
of Europeans who converted to Judaism (Koestler 1976).
Cultural isolation within this population has also been
encouraged. The present worldwide population of Ash-
kenazim is estimated to be 20 million, but the relevant
size of the Ashkenazi population in Gomel and Kiev is
unknown.
The Finnish population consisted of 432 unrelated
women who had benign breast disease and were resi-
dents of the city of Kuopio, ∼300 km northeast of Hel-
sinki. The southern and coastal regions of Finland are
considered to have been populated by ∼1,000 founders
∼2,000 years (80 generations) ago. However, migration
to the more northern and eastern parts, which include
Kuopio, occurred 400–500 years ago (20–25 genera-
tions) and involved a smaller subgroup of the Finnish
founder population (de la Chapelle 1993; Peltonen et al.
1999). The present size of the population in this region
is ∼500,000. Until very recent generations, this popu-
lation has been geographically isolated.
All DNA samples were extracted in each population’s
country of origin and were rendered anonymous before
analysis.
Markers and Maps
The maps (fig. 1) are 120–1,300 kb in length and have
8–18 biallelic polymorphisms. The marker maps have
very different densities, reflecting the various SNP-find-
ing strategies currently in use. No method aimed to com-
prehensively identify all the SNPs in the region.
Region 1 (chromosome 13q12-13).—Markers were
identified as a by-product of the human genome–se-
quencing project (Sanger Centre). This region on a contig
of 14 overlapping clones originally derived from two
separate alleles. In 2 of 13 instances, the overlaps con-
tained multiple mismatches as a result of genuine se-
quence differences between the two clones. Sequence
changes that generated RFLPs were chosen, and the al-
lele frequencies were checked in 20 further alleles. We
also used two previously identified microsatellite mark-
ers that had been sequenced within the contig. The dis-
tributions of allele sizes for these markers are bimodal,
and, for consistency with the SNPs, we treated these as
biallelic (short repeats vs. long repeats) in our analyses.
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We also used the only common SNP that generates an
amino acid substitution (N372H) within BRCA2.
Region 2 (chromosome 19q13.2).—This map was cre-
ated by GlaxoWellcome as part of a project to identify
an SNP in every 100-kb segment (bin) of a 4-Mb region
of chromosome 19 (Lai et al. 1998; Martin et al. 2000).
A subset of 12 adjacent markers over a region of 380
kb was chosen as being the most densely mapped area
within this long region.
Region 3 (chromosome 22q13.3-ter).—This map was
generated by the same method used for region 1 during
the sequencing of chromosome 22 (Dunham et al. 1999).
However, the region chosen for this analysis was a par-
ticularly long (120-kb) overlap of two clones from dif-
ferent alleles within the contig (E.D., unpublished data);
hence, it gives a much denser map. All the potential SNPs
that created RFLPs were identified, and the rare-allele
frequency was determined in 20 further individuals.
Genotyping Methods
Details of the markers used and the primers required
for their assay are shown in table 1.
RFLP.—PCRs were carried out using AmpliTaq Gold
(PE Biosystems), according to the manufacturer’s in-
structions, and the primers (MWG Biotech) listed in ta-
ble 1. The PCR fragments were then digested with the
corresponding enzyme (New England Biolabs) at the ap-
propriate temperature, and the digested fragments were
separated on 3% agarose gels (Gibco-BRL).
Microsatellites.—D13S260 and D13S171 were first
PCR-amplified using AmpliTaq Gold (PE Biosystems),
according to the manufacturer’s instructions. One of
each pair was labeled with a fluorescent dye (FAM or
TET) (PE Biosystems). Fragments in the range of
227–243 bp were obtained for D13S171, and fragments
of 158–174 bp were obtained for D13S260. A multiplex
of both PCR products, together with a GeneScan-500
TAMRA size marker and loading buffer (PE Biosys-
tems) was made and loaded onto a single lane of Se-
quagel-6 matrix (National Diagnostics) and was de-
tected on a model 373 Sequencer (PE Biosystems).
Fragment sizes were analyzed using GENOTYPER soft-
ware (PE Biosystems).
Taqman.—PCRs were carried out using 1# Taqman
universal PCR master mix, 900 nM forward and reverse
primers, and 200 nM/probe, in a 25-ml reaction. Am-
plification conditions on an MJ tetrad thermal cycler
(Genetic Research Instrumentation) were as follows: 1
step at 50C for 2 min, followed by 1 step at 95C for
10 min, and then 30 cycles of 95C for 15 s and 62C
for 1 min. The two probes for each assay were labeled
with VIC, for one allele, and with FAM, for the other
allele. The completed PCRs were then read on an ABI
Prism 7700 Sequence Detector and were analyzed using
the Allelic Discrimination Sequence Detection software
(PE Biosystems). Because no controls were included
(apart from two no-template controls), the genotypes
were manually assigned under dye components.
Statistical Methods
We used two distinct measures of disequilibrium, D′
and D, between marker pairs (Devlin and Risch 1995).
Each has advantages and disadvantages. D has the ad-
vantage that population genetics predicts a relationship
with recombination fraction: for a panmictic population
of constant size Ne, the expected value of D
2 (under the
competing effects of recombination and drift) is related
to the recombination fraction v by the formula 2ED p
. In association studies, D is also related to1(1 4N v)e
the power of LD mapping—in the sense that the sample
size required to detect an association in a case-control
study using an anonymous SNP marker linked to a dis-
ease-susceptibility gene is increased by a factor of ∼1/
D2, compared with that required when the “true” dis-
ease-associated polymorphism (where D is the LD
coefficient between the two polymorphisms) is used.
However, D has the disadvantage that the maximum
value achievable is dependent on the allele frequencies;
therefore, markers can have low D values even if no
recombination events have occurred between them. D′
has been suggested as an alternative measure because it
can vary between 0 and 1 for any combination of allele
frequencies; removal of the strong dependence on allele
frequency may be expected to give a stronger relation-
ship with genetic distance.
Because only genotype data on unrelated individuals
were available, two-locus haplotype frequencies were es-
timated using the expectation-maximization algorithm
(Weir 1996). These estimated frequencies were then used
to compute D and D′ for all possible pairs of loci within
one chromosomal region.
Evidence for differences in the average D′ between
populations at different distances were assessed by com-
putation of the statistic , where D′i is
′ ′ 2Sp S(D D ) Ni i
the D′ in population i and Ni is the size of population
i. The null distribution of S was evaluated by simulation,
in which the genotype of each individual was reassigned
by random permutation and S was recomputed 10,000
times. We also evaluated the distribution of D′ values
for all possible pairs of unlinked markers—this is sub-
sequently referred to as “baseline” LD. The Mann-Whit-
ney one-sided U-test was used to compare the distri-
butions of the D′ in each distance group with the
distribution for all possible unlinked marker pairs. This
test ignores the nonindependence of the D′ values.
Regression analyses were performed to formally an-
alyze the relationship between D′ and distance. Popu-
lation genetics predicts that the relationship between LD
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and distance (or recombination) should be of the fol-
lowing form: , where a and b′D p a/[1 b(distance)]
are parameters to be estimated.
Under this model, if there is no relationship between
D′ and distance, then b will be effectively 0 For each
marker pair, there are four D′ values, one from each
population, and one corresponding distance. We denote
this group as a “D′ set.” The statistical significance of
the fit of the model when b is estimated, compared with
b fixed at 0, is evaluated by random permutation of
distances in the D′ sets and refitting of the regression.
To determine whether this relationship is dependent
on the chromosome of origin, an additional parameter
is included in the regression, and the D′ set includes an
indicator for chromosome of origin: ′D p a/[1 (b
. In this calculation, b is the coefficient if thec)(distance)]
chromosome of origin is 19, and c is the additional factor
if the chromosome of origin is 22. (Chromosome 13 is
not used in this analysis, and, because too few data
points are available, only distances 120 kb are ana-
lyzed, so the two chromosome regions have equivalent
lengths). To evaluate statistical significance, chromo-
some of origin was randomly permuted in the D′ sets.
In both regressions, 2,000 permutations were performed
to estimate the level of statistical significance.
Results and Discussion
Allele Frequencies and Hardy-Weinberg Equilibrium
(HWE)
Marker-allele frequencies are similar among the four
populations (see table 1); however, because of the large
sample sizes, 31 of 38 markers show differences that are
significant at the 5% level. The fixation-index statistic
averaged over all the markers in all four populations is
.0067, and the maximum observed is .017. This is com-
patible with the values that Cavalli-Sforza et al. 1994)
reported for differences between European populations
( )..016 .002
The genotypes of all SNPs were tested for conformity
to HWE in each population (data not shown). Only one
marker (133033, on chromosome 22) appears to deviate
from HWE in all four populations. We have since shown
this to be an artifact due to a previously unknown rare
SNP within 28 bp of marker 133033, which caused mis-
calling in the Taqman assay. Of the remaining 37 mark-
ers, 8% in the East Anglians showed significant devia-
tion ( ) from HWE, 8% in the Finns, 19% in theP ! .05
Afrikaners, and 24% in the Ashkenazim. Thus, in both
the Afrikaner and Ashkenazi samples, we see more de-
viations from HWE than we would have expected. De-
viation from HWE could be an artifact if poor DNA
quality were to lead to difficulties in genotyping, but we
have no cause to suspect this in these samples.
LD in the Four Study Populations
The proportions of all marker pairs with significant
D′ values are 23% in the East Anglians, 19% in the
Afrikaners, and 36% in the Ashkenazim and the Finns.
The higher values in the Ashkenazim and the Finns may
reflect larger sample sizes—and hence greater power to
detect statistically significant values. Only for marker
pairs !5 kb apart are mean D′ values in the four pop-
ulations significantly different from one another (Pp
). Pair-wise D′ values are positively correlated for.003
all pairs of populations (correlation coefficients .41–.64),
with no clear differences by marker distance. This re-
flects the common origin of most haplotypes.
We have concentrated on SNPs with a minor allele
frequency 1.1 because we expect that these will have
characteristics similar to those of the common disease-
susceptibility polymorphisms that genomewide associ-
ation studies are intended to detect. In results similar to
those of two recent studies (Eaves et al. 2000; Taillon-
Miller et al. 2000), we find little evidence for major
differences in the extent of LD among the European
populations studied, and this suggests that no large Eu-
ropean population will prove to have a specific advan-
tage for association studies focused on ancient, com-
mon disease-susceptibility alleles (see the LD and
Physical Distance subsection). This is perhaps not sur-
prising, given that common polymorphisms are probably
ancient, predating the formation of modern human
populations.
LD and Physical Distance
We have summarized the relationship between LD and
physical distance as distributions of all D′ values (fig. 2),
mean D′ (fig. 3), and proportion of marker pairs with
(fig. 4), against physical distance betweenD 1 .30
marker pairs, for all permutations of pairs. The statistics
D′ and D show generally similar patterns. For marker
pairs 200 kb apart, the D′ values are significantly
higher than those for unlinked pairs (the baseline), in all
four populations (all P values.05) (fig. 2). At 200–500
kb, the Finns still show highly significant differences
from baseline ( ), but all other populationsPp .0003
show at least borderline differences from baseline at this
distance ( ). For marker pairs 1500 kb apart, noP  .06
population shows any significant difference from base-
line (all P values 1.25)
For the combined population samples, mean D′ de-
clines from .68 for marker pairs !5 kb apart to .05 for
marker pairs 200–500 kb apart (fig. 3). The regression
(see the Subjects and Methods section) provides evidence
for an inverse relationship between D′ and distance
( ; ). The mean D′ is higher for mark-bp .0338 P ! .0005
ers 100–200 kb apart than it is for those either 50–100
kb or 200–500 kb apart, although any reason, other
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Figure 2 Distribution of D′ LD measure with physical distance (in kb). A, East Anglians. B, Afrikaners. C, Ashkenazim. D, Finns. The
black horizontal bars represent the mean D′, whereas the median is represented by a dotted line. The boxes represent the upper and lower 75th
percentiles. The horizontal tick marks correspond to the upper and lower 95th percentiles. The proportion of pairs with significant D′ for each
distance group is shown in brackets, and the denominator also shows the number of data points in each distance group. Note that the distance
groups correspond approximately to a logarithmic scale
than chance, for this finding is presently obscure. There
is some evidence for a difference, in the rate of decline
of LD, between the chromosome 19 region and the chro-
mosome 22 region (fig. 3) The addition of a chromosome
effect to the regression model reveals evidence that LD
in the chromosome 22 region declines slightly more rap-
idly than it does in the chromosome 19 region (cp
; )..485 Pp .0005
To obtain accurate estimates of LD, we used large
sample sizes (1230 individuals). Small sample sizes pro-
vide estimates of LD that are biased upward, since values
of LD must always be positive. This can lead to an un-
derestimation of the rate of decay of LD with increasing
physical distance. In general, we find that LD declines
rapidly with distance. The mean D′ value for markers
5–10 kb apart is less than half that for markers !5 kb
apart (fig. 3). In this respect, our conclusions are con-
sistent with the simulations by Kruglyak (1999), who
showed that, when a theoretical population-genetics
model is used, a rapid decline in LD at distances 13 kb
results. However, Kruglyak’s results also predict that
there should be no detectable LD between marker pairs
separated by 10 kb, whereas our results indicate both
significant LD between marker pairs 20 kb apart and
some evidence for LD above baseline, even at distances
of 500 kb. These differences could reflect a more com-
plex early demographic history than that modeled by
Kruglyak. There is a potential concern that some of the
observed LD may be artifactual, resulting from popu-
lation stratification; however, we find no evidence of
significant LD among pairs of unlinked markers (fig. 2),
which would have been evidence for such stratification
(Lautenberger et al. 2000). Our data also contradict
those of Jorde et al. (1994), which suggest that there is
little correlation between LD measures and physical dis-
tance, for markers 50 kb apart. In contrast, we see a
strong relationship between distance and the propor-
tion of markers in LD, at all distances. This difference
could be because Jorde et al. studied multiallelic micro-
satellite markers, which are more mutable—and hence
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Figure 3 Mean D′ score by distance (in kb), for all three regions combined. Inset shows the same curves for the individual regions of
chromosomes 19 and 22. The asymmetric distribution of the distances between markers across the chromosome 13 map does not generate a
continuous curve, so it is not shown here.
have many newer alleles—rather than the older, common
SNPs used here. Taillon-Miller et al. (2000), using SNP
markers, found extensive LD in some regions of the X
chromosome and much less LD in another region, results
suggestive of a recombination hotspot in the second re-
gion; whereas the three autosomal regions that we have
looked at show uniform, but much less extensive, LD
and no evidence for recombination hotspots.
Despite the strong relationship between LD and dis-
tance, we find a high proportion of physically close
marker pairs that are not in strong LD with one another.
As shown in figure 4, at 5 kb apart, ∼50% of marker
pairs are not in sufficient LD ( ) (see the SubjectsD 1 .3
and Methods section) to be useful for association studies.
At 20–50 kb apart, virtually no marker pairs display
“useful” levels of LD, in any of the populations. Of
course, it is possible that our results are not typical of
the distribution of LD over the whole genome. An im-
portant issue is whether LD is likely to be greater across
coding sequences. None of the markers in this study fall
within the same exon, so it is not possible to compare
LD within and between exons. However, it is possible
to compare both the number of genes in each map and
the footprint that their exons leave on the region. There
are eight known or predicted genes in chromosome
13q12 (Sanger 2000). The exons of these comprise only
54.8 kb (3.9%) of the region, but they are arranged
across ∼80% of the 1.3 Mb studied. In chromosome
19q13.2, there are six known genes: the APO C4/C2/
C1/E gene cluster, PRR, and PVR. Nine of the 12 SNPs
studied in this region fall within these genes; however,
the total amount of coding sequence and its footprint
within the region is uncertain. There are no predicted
genes or coding sequence within the chromosome
22q13.3-ter region that we studied. The rate of decline
of LD with distance is a little slower in the regions on
chromosomes 19 and 13 than in the region on chro-
mosome 22 (fig. 3), but it is not clear that this can be
attributed to differences in the amount of coding se-
quence. Our data are generally consistent with other
reported data, across coding regions. Thus, Clark et al.
(1998) examined all base substitutions detected in a 9.7-
kb fragment of the LPL gene in 71 subjects. They found
that only 36% of pairs were in strong LD. One inter-
esting exception may be the BRCA1 gene, in which all
common coding SNPs across almost 100 kb are in very
strong LD (Friedman et al. 1994; Durocher et al. 1996;
Dunning et al. 1997).
One way to assess the usefulness of LD for mapping
is to assume that one of the markers is the functional
(disease-causing) polymorphism, and to ask what in-
crease in sample size would be required for detection of
a disease association if a neighboring polymorphism in
LD were typed instead. A practical upper limit to the
increase in sample size is probably 10-fold for most dis-
orders (Kruglyak 1999), which corresponds to Dp
; on this basis, only about 50% of marker pairs.1 ≈ .3
in our study are in “useful” LD at !5 kb (fig. 4).
The existence of a strong inverse relationship between
LD and physical distance means that a complete-genome
scan for disease association is theoretically possible.
However, if our results are representative of the whole
genome, they indicate that a very dense map of markers
will be required. We estimate that ∼600,000 markers
Dunning et al.: LD Physical Distance and Population History 1553
Figure 4 Proportion of marker pairs with by distance (kb)D 1 .3
will be required across the genome. Thus, association
studies based on polymorphisms within all known genes,
once they are all mapped, rather than on the whole ge-
nome, may ultimately prove to be a more effective strat-
egy.
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